Cargando…

Population‐based analysis of perioperative chemotherapy use, interventions requiring hospitalization and atheroembolic events among patients with non‐metastatic muscle‐invasive bladder cancer

INTRODUCTION: Utilization of neoadjuvant chemotherapy (NC) in muscle invasive bladder cancer (MIBC) is increasingly recognized as standard of care but trends of use in Ontario remain unknown. Currently, there remains knowledge gaps regarding the effects of perioperative chemotherapy on the rates of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benidir, Tarik, Herrera‐Caceres, Jaime, Wallis, Christopher, Lajkosz, Katherine, Fleshner, Neil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026920/ https://www.ncbi.nlm.nih.gov/pubmed/33710797 http://dx.doi.org/10.1002/cam4.3805

Ejemplares similares

Atheroembolic Renal Disease
por: Singh, Narinder P., et al.
Publicado: (2020)

Cholesterol crystal embolism (atheroembolism)
por: VENTURELLI, CHIARA, et al.
Publicado: (2006)

Atheroembolic Renal Disease: A Case Series
por: Jansi Prema, KS, et al.
Publicado: (2019)

Estimating the optimal perioperative chemotherapy utilization rate for muscle‐invasive bladder cancer
por: Karim, Safiya, et al.
Publicado: (2019)

An atypical presentation of a severe and massive atheroembolic disease
por: Falcão, Luis Pedro, et al.
Publicado: (2018)

Atheroembolic kidney disease: The under‐recognized silent killer
por: Ștefan, Gabriel, et al.
Publicado: (2021)

Required efficacy for novel therapies in BCG‐unresponsive non‐muscle invasive bladder cancer: Do current recommendations really reflect clinically meaningful outcomes?
por: Wettstein, Marian S., et al.
Publicado: (2020)

Favorable outcome in atheroembolic renal disease with pulse steroid therapy
por: Sharma, A., et al.
Publicado: (2012)

A rare presentation of spontaneous atheroembolic renal disease: A case report
por: Piranavan, Paramarajan, et al.
Publicado: (2019)

Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers
por: Clark, Roderick, et al.
Publicado: (2022)

Contrast induced nephropathy has to be differentiated from kidney injury due to atheroembolic disease
por: Nasri, Hamid, et al.
Publicado: (2013)

Intimal angiosarcoma of the descending aorta presenting as atheroembolism: case report and description of intravascular biopsy
por: Bartolomé Sánchez, Alejandra, et al.
Publicado: (2023)

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder
por: Guancial, Elizabeth A, et al.
Publicado: (2014)

Prevention from Atheroembolization during Thoracic Endovascular Aortic Repair in Patients with Severe Atherosclerosis in the Aorta
por: Yamauchi, Takashi, et al.
Publicado: (2019)

Iloprost in Acute Post-kidney Transplant Atheroembolism: A Case Report of Two Successful Treatments
por: Corradetti, Valeria, et al.
Publicado: (2020)

A Rare Case of Coronavirus Disease 2019 Survival in an Elderly Patient With Atheroembolic Renal Disease
por: Cavanna, Luigi, et al.
Publicado: (2021)

Carboplatin Induction Chemotherapy in Clinically Lymph Node–positive Bladder Cancer
por: von Deimling, Markus, et al.
Publicado: (2023)

Perioperative immunotherapy for muscle-invasive bladder cancer
por: Kim, In-Ho, et al.
Publicado: (2020)

Thromboembolic Events During Treatment with Cisplatin-based Chemotherapy in Metastatic Testicular Germ-cell Cancer 2000–2014: A Population-based Cohort Study
por: Haugnes, Hege S., et al.
Publicado: (2021)

Salvage Radiotherapy Following Partial Gland Ablation for Prostate Cancer: Functional and Oncological Outcomes
por: Qaoud, Yazan, et al.
Publicado: (2020)

Idiopathic cholesterol crystal embolism with atheroembolic renal disease and blue toes syndrome: A case report
por: Cheng, De-Jin, et al.
Publicado: (2022)

Emerging perioperative therapeutic approaches in muscle invasive bladder cancer
por: Patil, Goutham, et al.
Publicado: (2022)

Does perioperative chemotherapy improve survival in upper tract urothelial carcinoma? A population based analysis
por: Goldberg, Hanan, et al.
Publicado: (2018)

Perioperative Chemotherapy Could Not Improve the Prognosis of Gastric Cancer Patients With Mismatch Repair Deficiency: A Multicenter, Real-World Study
por: Zhao, Lulu, et al.
Publicado: (2023)

Statin Use and Survival Among Men Receiving Androgen-Ablative Therapies for Advanced Prostate Cancer: A Systematic Review and Meta-analysis
por: Jayalath, Viranda H., et al.
Publicado: (2022)

The Impact of Primary Versus Secondary Muscle-invasive Bladder Cancer at Diagnosis on the Response to Neoadjuvant Chemotherapy
por: D'Andrea, David, et al.
Publicado: (2022)

Docetaxel, Cisplatin, and 5‐Fluorouracil as perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma
por: Fiteni, Frédéric, et al.
Publicado: (2016)

Perioperative CRP: A novel inflammation‐based classification in gastric cancer for recurrence and chemotherapy benefit
por: Lu, Jun, et al.
Publicado: (2020)

Use of perioperative chemotherapy in colorectal cancer metastatic to the liver
por: Symonds, Lynn K, et al.
Publicado: (2019)

LINC00857 expression predicts and mediates the response to platinum‐based chemotherapy in muscle‐invasive bladder cancer
por: Dudek, Aleksandra M., et al.
Publicado: (2018)

Human Gut Mycobiome and Fungal Community Interaction: The Unknown Musketeer in the Chemotherapy Response Status in Bladder Cancer
por: Bukavina, Laura, et al.
Publicado: (2022)

First‐line therapy of bevacizumab plus chemotherapy versus cetuximab plus chemotherapy for metastatic colorectal cancer patients with mucinous adenocarcinoma or mucinous component
por: Zhou, Yu‐Wen, et al.
Publicado: (2021)

Comparative Effectiveness of Palliative Chemotherapy in Metastatic Breast Cancer: A Real‐World Evidence Analysis
por: Feinberg, Bruce, et al.
Publicado: (2020)

Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs
por: Hao, Zhonglin, et al.
Publicado: (2022)

Development of the First Patient-centred Set of Outcomes for Muscle-invasive and Metastatic Bladder Cancer: A Multicentre Initiative
por: Reesink, Daan J., et al.
Publicado: (2021)

Immunotherapy against metastatic bladder cancer by combined administration of granulocyte macrophage‐colony stimulating factor and interleukin‐2 surface modified MB49 bladder cancer stem cells vaccine
por: Wang, Chun‐yan, et al.
Publicado: (2017)

Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer
por: de Cuba, E. M. V., et al.
Publicado: (2016)

Prediction of Metastatic Patterns in Bladder Cancer: Spatiotemporal Progression and Development of a Novel, Web-based Platform for Clinical Utility
por: Mason, Jeremy, et al.
Publicado: (2021)

Atheroembolization and potential air embolization during aortic declamping in open repair of a pararenal aortic aneurysm: A case report
por: Dregelid, Einar Børre, et al.
Publicado: (2016)

Safety and Feasibility of Additional Tumor Debulking to First‐Line Palliative Combination Chemotherapy for Patients with Multiorgan Metastatic Colorectal Cancer
por: Gootjes, Elske C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g48ktdupr7hpg114s9v3dpgq4n